Literature DB >> 16488494

Non-enzymatic regeneration of nicotinamide and flavin cofactors for monooxygenase catalysis.

F Hollmann1, K Hofstetter, A Schmid.   

Abstract

Biocatalytic oxygenation chemistry is a rapidly evolving field in which monooxygenases are the tools of choice. Monooxygenases catalyze many industrially important synthetic transformations; however, their use in preparative applications is hampered by their intrinsic requirement for reducing equivalents. As a result, non-enzymatic strategies--where the reducing equivalents are introduced directly into the catalytic cycle--are being developed to supersede the well-established enzymatic NAD(P)H regeneration systems currently in use. In this review we summarize and evaluate recent achievements in this area.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488494     DOI: 10.1016/j.tibtech.2006.02.003

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  11 in total

1.  Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes.

Authors:  V Köhler; Y M Wilson; M Dürrenberger; D Ghislieri; E Churakova; T Quinto; L Knörr; D Häussinger; F Hollmann; N J Turner; T R Ward
Journal:  Nat Chem       Date:  2012-11-25       Impact factor: 24.427

2.  An efficient light-driven P450 BM3 biocatalyst.

Authors:  Ngoc-Han Tran; Daniel Nguyen; Sudharsan Dwaraknath; Sruthi Mahadevan; Garrett Chavez; Angelina Nguyen; Thanh Dao; Sarah Mullen; Thien-Anh Nguyen; Lionel E Cheruzel
Journal:  J Am Chem Soc       Date:  2013-09-19       Impact factor: 15.419

3.  Asymmetric Epoxidation and Sulfoxidation Catalyzed by a New Styrene Monooxygenase from Bradyrhizobium.

Authors:  Can Cui; Hui Lin; Wei Pu; Chao Guo; Yan Liu; Xiao-Qiong Pei; Zhong-Liu Wu
Journal:  Appl Biochem Biotechnol       Date:  2020-08-18       Impact factor: 2.926

4.  Nicotinamide-independent asymmetric bioreduction of C=C-bonds via disproportionation of enones catalyzed by enoate reductases.

Authors:  Clemens Stueckler; Tamara C Reiter; Nina Baudendistel; Kurt Faber
Journal:  Tetrahedron       Date:  2010-01-16       Impact factor: 2.457

5.  NAD(P)H-independent asymmetric C=C bond reduction catalyzed by ene reductases by using artificial co-substrates as the hydrogen donor.

Authors:  Christoph K Winkler; Dorina Clay; Marcello Entner; Markus Plank; Kurt Faber
Journal:  Chemistry       Date:  2013-12-30       Impact factor: 5.236

6.  Cofactor Specificity Engineering of Streptococcus mutans NADH Oxidase 2 for NAD(P)(+) Regeneration in Biocatalytic Oxidations.

Authors:  Barbara Petschacher; Nicole Staunig; Monika Müller; Martin Schürmann; Daniel Mink; Stefaan De Wildeman; Karl Gruber; Anton Glieder
Journal:  Comput Struct Biotechnol J       Date:  2014-02-26       Impact factor: 7.271

7.  Rhodium-coordinated poly(arylene-ethynylene)-alt-poly(arylene-vinylene) copolymer acting as photocatalyst for visible-light-powered NAD⁺/NADH reduction.

Authors:  Kerstin T Oppelt; Jacek Gasiorowski; Daniel Ayuk Mbi Egbe; Jan Philipp Kollender; Markus Himmelsbach; Achim Walter Hassel; Niyazi Serdar Sariciftci; Günther Knör
Journal:  J Am Chem Soc       Date:  2014-09-02       Impact factor: 15.419

8.  Effect of cell permeability and dehydrogenase expression on octane activation by CYP153A6-based whole cell Escherichia coli catalysts.

Authors:  Bronwyn E White; Caryn J Fenner; Martha S Smit; Susan T L Harrison
Journal:  Microb Cell Fact       Date:  2017-09-20       Impact factor: 5.328

9.  Improved soluble expression and use of recombinant human renalase.

Authors:  Clifford S Morrison; Elena E Paskaleva; Marvin A Rios; Thomas R Beusse; Elaina M Blair; Lucy Q Lin; James R Hu; Aidan H Gorby; David R Dodds; William B Armiger; Jonathan S Dordick; Mattheos A G Koffas
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

Review 10.  Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites.

Authors:  Giovanna Di Nardo; Gianfranco Gilardi
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.